|
시장보고서
상품코드
1762267
신경혈전제거 기기 시장 규모, 점유율, 동향, 산업 분석 보고서 : 제품별, 최종 용도별, 지역별 - 시장 예측(2025-2034년)Neurothrombectomy Devices Market Size, Share, Trends, Industry Analysis Report: By Product, End Use, and Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면, 신경혈전제거 기기 시장 규모는 2034년까지 14억 1,833만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.
신경혈전제거 기기 시장은 급성 허혈성 뇌졸중 환자의 뇌에서 혈전을 제거하고 혈류를 회복시켜 신경학적 합병증을 예방하기 위해 고안된 의료기기에 초점을 맞추고 있습니다. 이 시장은 전 세계 뇌졸중 발병률 증가, 최소침습적 시술의 채택 증가, 혈전제거 및 흡입 장치의 지속적인 기술 발전으로 인해 크게 성장하고 있습니다. 신경혈전제거 기기의 시장 기회는 의료 인프라와 인식 개선으로 고급 뇌졸중 치료에 대한 수요가 증가하고 있는 신흥국 시장에서 창출되고 있습니다. 주요 동향으로는 뇌졸중 진단을 위한 인공지능의 통합, 제품 혁신을 위한 임상 연구 확대, 선진국 시장에서의 상환 지원 확대 등을 들 수 있습니다. 규제 당국의 승인과 시장 참여자들 간의 전략적 제휴가 증가함에 따라 신경혈전제거 기기 시장은 향후 몇 년 동안 더욱 확대될 것으로 예상됩니다.
신경혈전제거 기기 시장 보고서 하이라이트
제품별로는 혈전 회수 장치가 기계적 혈전제거술의 높은 효과로 인해 2024년 신경혈전제거 기기 시장 매출에서 가장 큰 점유율을 차지했습니다. 반면, 흡입/흡입 장치는 진공 보조 혈전제거 기술의 발전으로 인해 가장 높은 성장률을 보일 것으로 예상됩니다.
한편, 외래 수술 센터는 최소침습적 수술과 환자의 조기 회복에 대한 수요 증가로 인해 빠르게 성장하고 있습니다.
북미는 높은 의료 인프라, 높은 뇌졸중 발병률, 강력한 상환 정책으로 인해 가장 큰 시장 점유율을 차지하고 있으며, 아시아태평양은 의료 투자 증가, 인지도 향상, 뇌졸중 관리 시설의 개선으로 인해 가장 빠르게 성장하는 지역입니다.
시장 주요 기업으로는 Abbott Laboratories, Acandis GmbH, AngioDynamics, Inc., Argon Medical Devices, Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Johnson & Johnson Services, Inc. (Cerenovus), LeMaitre Vascular, Inc., Medtronic plc, MicroVention, Inc. (a subsidiary of Terumo Corporation), Penumbra, Inc., Phenox GmbH, Stryker Corporation, Terumo Corporation, Vesalio, LLC. 등이 있습니다.
목차
제1장 소개
제2장 주요 요약
제3장 조사 방법
제4장 세계의 신경혈전제거 기기 시장 인사이트
- 시장 현황
- 신경혈전제거 기기 시장 역학
- 성장 촉진요인과 기회
- 허혈성 뇌졸중 발생률 상승
- 기계적 혈전제거술의 진보
- 성장 억제요인과 과제
- 높은 시술 비용
- 성장 촉진요인과 기회
- PESTEL 분석
- 신경혈전제거 기기 시장 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 신경혈전제거 기기 시장 : 제품별
- 주요 조사 결과
- 소개
- 혈전 제거기
- 흡인 기기
- 혈관 스네어
제6장 세계의 신경혈전제거 기기 시장 : 최종 용도별
- 주요 조사 결과
- 소개
- 병원
- 구급 클리닉
- 외래 수술 센터
제7장 세계의 신경혈전제거 기기 시장 : 지역별
- 주요 조사 결과
- 소개
- 신경혈전제거 기기 시장 평가 : 지역별, 2020-2034년
- 북미
- 북미 : 제품별, 2020-2034년
- 북미 : 최종 용도별, 2020-2034년
- 미국
- 캐나다
- 유럽
- 유럽 : 제품별, 2020-2034년
- 유럽 : 용도별, 최종 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 제품별, 2020-2034년
- 아시아태평양 : 최종 용도별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 제품별, 2020-2034년
- 중동 및 아프리카 : 최종 용도별, 2020-2034년
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 제품별, 2020-2034년
- 라틴아메리카 : 최종 용도별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제8장 경쟁 구도
- 확대와 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제9장 기업 개요
- Abbott Laboratories
- Acandis GmbH
- AngioDynamics, Inc.
- Argon Medical Devices, Inc.
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- Johnson & Johnson Services, Inc.(Cerenovus)
- LeMaitre Vascular, Inc.
- Medtronic plc
- MicroVention, Inc.(a subsidiary of Terumo Corporation)
The neurothrombectomy devices market size is expected to reach USD 1,418.33 million by 2034, according to a new study by Polaris Market Research. The report "Neurothrombectomy Devices Market Size, Share, Trends, Industry Analysis Report: By Product (Clot Retrievers, Aspiration/Suction Devices, and Vascular Snares), End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The neurothrombectomy devices market focuses on medical instruments designed to remove blood clots from the brain in patients suffering from acute ischemic stroke, helping restore blood flow and prevent neurological complications. The market is experiencing significant growth due to the rising incidence of stroke globally, increasing adoption of minimally invasive procedures, and continuous technological advancements in clot retrieval and aspiration devices. Neurothrombectomy devices market opportunities are emerging in developing regions where improving healthcare infrastructure and awareness are driving demand for advanced stroke treatments. Key trends include the integration of artificial intelligence for stroke diagnosis, expanding clinical research for product innovation, and growing reimbursement support in developed markets. With increasing regulatory approvals and strategic collaborations among market players, the neurothrombectomy devices market is expected to expand further in the coming years.
Neurothrombectomy Devices Market Report Highlights
By product, the clot retrievers segment accounted for the largest share of the neurothrombectomy devices market revenue in 2024 due to their high efficacy in mechanical thrombectomy procedures, while aspiration/suction devices are expected to witness the highest growth due to advancements in vacuum-assisted clot removal technologies.
By end use, the hospitals segment dominated the neurothrombectomy devices market share as they are the primary centers for stroke treatment with well-equipped neurovascular units, while ambulatory surgical centers are experiencing rapid growth due to increasing demand for minimally invasive procedures and faster patient recovery.
North America holds the largest market share due to advanced healthcare infrastructure, high stroke incidence, and strong reimbursement policies, while Asia-Pacific is the fastest-growing region driven by rising healthcare investments, increasing awareness, and improving stroke management facilities.
A few major companies in the market are Abbott Laboratories; Acandis GmbH; AngioDynamics, Inc.; Argon Medical Devices, Inc.; Boston Scientific Corporation; Edwards Lifesciences Corporation; Johnson & Johnson Services, Inc. (Cerenovus); LeMaitre Vascular, Inc.; Medtronic plc; MicroVention, Inc. (a subsidiary of Terumo Corporation); Penumbra, Inc.; Phenox GmbH; Stryker Corporation; Terumo Corporation; and Vesalio, LLC.
Polaris Market Research has segmented the neurothrombectomy devices market report on the basis of product, end use, and region:
By Product Outlook (Revenue - USD Million, 2020-2034)
Clot Retrievers
Aspiration/Suction Devices
Vascular Snares
By End Use Outlook (Revenue - USD Million, 2020-2034)
Hospitals
Emergency Clinics
Ambulatory Surgical Centers
By Regional Outlook (Revenue - USD Million, 2020-2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Neurothrombectomy Devices Market Insights
- 4.1. Neurothrombectomy Devices Market - Market Snapshot
- 4.2. Neurothrombectomy Devices Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Incidence of Ischemic Strokes
- 4.2.1.2. Advancements in Mechanical Thrombectomy Procedures
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High procedural costs
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Neurothrombectomy Devices Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Neurothrombectomy Devices Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 5.3. Clot Retrievers
- 5.3.1. Global Neurothrombectomy Devices Market, by Clot Retrievers, by Region, 2020-2034 (USD Million)
- 5.4. Aspiration/Suction Devices
- 5.4.1. Global Neurothrombectomy Devices Market, by Aspiration/Suction Devices, by Region, 2020-2034 (USD Million)
- 5.5. Vascular Snares
- 5.5.1. Global Neurothrombectomy Devices Market, by Vascular Snares, by Region, 2020-2034 (USD Million)
6. Global Neurothrombectomy Devices Market, by End-Use
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 6.3. Hospitals
- 6.3.1. Global Neurothrombectomy Devices Market, by Hospitals, by Region, 2020-2034 (USD Million)
- 6.4. Emergency Clinics
- 6.4.1. Global Neurothrombectomy Devices Market, by Emergency Clinics, by Region, 2020-2034 (USD Million)
- 6.5. Ambulatory Surgical Centers
- 6.5.1. Global Neurothrombectomy Devices Market, by Ambulatory Surgical Centers, by Region, 2020-2034 (USD Million)
7. Global Neurothrombectomy Devices Market, by Geography
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Neurothrombectomy Devices Market Assessment, By Geography, 2020-2034 (USD Million)
- 7.3. Neurothrombectomy Devices Market - North America
- 7.3.1. North America: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.3.2. North America: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.3.3. Neurothrombectomy Devices Market - U.S.
- 7.3.3.1. U.S.: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.3.3.2. U.S.: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.3.4. Neurothrombectomy Devices Market - Canada
- 7.3.4.1. Canada: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.3.4.2. Canada: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.4. Neurothrombectomy Devices Market - Europe
- 7.4.1. Europe: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.4.2. Europe: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.4.3. Neurothrombectomy Devices Market - UK
- 7.4.3.1. UK: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.4.3.2. UK: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.4.4. Neurothrombectomy Devices Market - France
- 7.4.4.1. France: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.4.4.2. France: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.4.5. Neurothrombectomy Devices Market - Germany
- 7.4.5.1. Germany: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.4.5.2. Germany: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.4.6. Neurothrombectomy Devices Market - Italy
- 7.4.6.1. Italy: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.4.6.2. Italy: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.4.7. Neurothrombectomy Devices Market - Spain
- 7.4.7.1. Spain: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.4.7.2. Spain: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.4.8. Neurothrombectomy Devices Market - Netherlands
- 7.4.8.1. Netherlands: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.4.8.2. Netherlands: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.4.9. Neurothrombectomy Devices Market - Russia
- 7.4.9.1. Russia: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.4.9.2. Russia: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.4.10. Neurothrombectomy Devices Market - Rest of Europe
- 7.4.10.1. Rest of Europe: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.4.10.2. Rest of Europe: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.5. Neurothrombectomy Devices Market - Asia Pacific
- 7.5.1. Asia Pacific: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.5.2. Asia Pacific: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.5.3. Neurothrombectomy Devices Market - China
- 7.5.3.1. China: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.5.3.2. China: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.5.4. Neurothrombectomy Devices Market - India
- 7.5.4.1. India: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.5.4.2. India: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.5.5. Neurothrombectomy Devices Market - Malaysia
- 7.5.5.1. Malaysia: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.5.5.2. Malaysia: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.5.6. Neurothrombectomy Devices Market - Japan
- 7.5.6.1. Japan: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.5.6.2. Japan: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.5.7. Neurothrombectomy Devices Market - Indonesia
- 7.5.7.1. Indonesia: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.5.7.2. Indonesia: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.5.8. Neurothrombectomy Devices Market - South Korea
- 7.5.8.1. South Korea: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.5.8.2. South Korea: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.5.9. Neurothrombectomy Devices Market - Australia
- 7.5.9.1. Australia: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.5.9.2. Australia: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.5.10. Neurothrombectomy Devices Market - Rest of Asia Pacific
- 7.5.10.1. Rest of Asia Pacific: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.5.10.2. Rest of Asia Pacific: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.6. Neurothrombectomy Devices Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.6.2. Middle East & Africa: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.6.3. Neurothrombectomy Devices Market - Saudi Arabia
- 7.6.3.1. Saudi Arabia: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.6.3.2. Saudi Arabia: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.6.4. Neurothrombectomy Devices Market - UAE
- 7.6.4.1. UAE: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.6.4.2. UAE: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.6.5. Neurothrombectomy Devices Market - Israel
- 7.6.5.1. Israel: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.6.5.2. Israel: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.6.6. Neurothrombectomy Devices Market - South Africa
- 7.6.6.1. South Africa: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.6.6.2. South Africa: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.6.7. Neurothrombectomy Devices Market - Rest of Middle East & Africa
- 7.6.7.1. Rest of Middle East & Africa: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.6.7.2. Rest of Middle East & Africa: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.7. Neurothrombectomy Devices Market - Latin America
- 7.7.1. Latin America: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.7.2. Latin America: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.7.3. Neurothrombectomy Devices Market - Mexico
- 7.7.3.1. Mexico: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.7.3.2. Mexico: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.7.4. Neurothrombectomy Devices Market - Brazil
- 7.7.4.1. Brazil: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.7.4.2. Brazil: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.7.5. Neurothrombectomy Devices Market - Argentina
- 7.7.5.1. Argentina: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.7.5.2. Argentina: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
- 7.7.6. Neurothrombectomy Devices Market - Rest of Latin America
- 7.7.6.1. Rest of Latin America: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
- 7.7.6.2. Rest of Latin America: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
- 9.1. Abbott Laboratories
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Acandis GmbH
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. AngioDynamics, Inc.
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Argon Medical Devices, Inc.
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Boston Scientific Corporation
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Edwards Lifesciences Corporation
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Johnson & Johnson Services, Inc. (Cerenovus)
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. LeMaitre Vascular, Inc.
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Medtronic plc
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. MicroVention, Inc. (a subsidiary of Terumo Corporation)
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
